SCHEMBL7184589

SCHEMBL7184589

Cc1ccc(OC(C)C)c(/C=C/C(=O)c2ccc(C(=O)N(C)C)cc2)c1OC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
ALDH1A1 P00352 2/20 0.36
KRAS P01116 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MAOA P21397 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184592 1.00 ABCG2 (0.40) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7190676 0.86 CAPN1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7190678 0.86 CAPN1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7188035 0.86 PDE4A (0.38) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7188038 0.86 PDE4A (0.38) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7184488 0.85 CA1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7184482 0.85 CA1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7180369 0.85 ABCG2 (0.57) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7180373 0.85 ABCG2 (0.57) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7184268 0.85 ALDH1A1 (0.37) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed